Aprepitant
Top View
- Pharmacogenomic Associations Tables
- Neurokinin-1 (NK1) Receptor Antagonists and Combinations
- Functional Dyspepsia and Gastroparesis
- EMEND (Aprepitant and Fosaprepitant) RATIONALE FOR
- Preferred Drug List Drug Class Review Announcement
- Pharmacy Benefit Guide Together with CCHP PO Box 1997 - MS 6280 | Milwaukee, WI 53201-1997 Toll-Free: 1-844-201-4677 | Togethercchp.Org
- 56 Mar 2006 Produced by NHS Tayside Drug and Therapeutics Committee Medicines Advisory Group (MAG)
- Therapeutic Drug Class
- Antiemetic Studies on the NK1 Receptor Antagonist Aprepitant
- For Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Adults
- Aprepitant Drug Monograph
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- National Rules for Drug–Drug Interactions: Are They Appropriate for Tertiary Hospitals?
- Aprepitant to Control Nausea and Vomiting in the Pediatric ICU Setting
- Comparison of Antiemetic Efficacy Between Single and Repeated
- Anaphylactic Shock and Cardiac Arrest
- January 1, 2017
- The Effects of Drugs on Human Models of Emotional Processing: an Account of Antidepressant Drug Treatment Abbie Pringle, Phd; Catherine J